An observational study in Vertebral Body Compression, sponsored by Mohammad ARAB MOTLAGH. Completed. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-05-22.
Sponsored by Mohammad ARAB MOTLAGH · Observational
Balloon kyphoplasty is a well-established treatment option to achieve pain relief and to correct kyphotic deformity caused by osteoporotic vertebral compression fracture. However, it has been demonstrated that reduction is partly lost as balloon is deflated in the vertebral body. An intravertebral expander was developed for better reduction and maintenance of vertebral body height while cement is injected. This study evaluates the efficacy of kyphoplasty with a new intravertebral expander with regard to correction of kyphosis angel and to restoration of vertebral body height.
Mohammad ARAB MOTLAGH is the lead sponsor of 4 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with new osteoporotic vertebral body fractures who were eligible for kyphoplasty and were treated with kyphoplasty, were observed prospectively 12 months after the surgery. In the follow-up period the clinical and radiological data were collected
Exclusion Criteria:
Patients underwent kyphoplasty with an intravertebral expander
Procedure: Kyphoplasty
Fractured vertebral body was reduced with an intravertebral expander and was cement augmented thereafter
Radiological evaluation
Kyphosis angle in degree and vertebral body height in cm are measured on lateral x-ray
Time frame: 12 months
Visual Analogue Scale
Scores range from 0 (no pain) to 10 (worst possible pain)
Time frame: 12 months
No study locations are listed for this record.
This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Mohammad ARAB MOTLAGH